150 related articles for article (PubMed ID: 37597407)
1. Development and validation of a mathematical model for evaluating shear-induced damage of von Willebrand factor.
Li Y; Xi Y; Wang H; Sun A; Wang L; Deng X; Chen Z; Fan Y
Comput Biol Med; 2023 Sep; 164():107379. PubMed ID: 37597407
[TBL] [Abstract][Full Text] [Related]
2. A mathematical model for assessing shear induced bleeding risk.
Li Y; Wang H; Xi Y; Sun A; Wang L; Deng X; Chen Z; Fan Y
Comput Methods Programs Biomed; 2023 Apr; 231():107390. PubMed ID: 36745955
[TBL] [Abstract][Full Text] [Related]
3. Stress and Exposure Time on von Willebrand Factor Degradation.
Jhun CS; Siedlecki C; Xu L; Lukic B; Newswanger R; Yeager E; Reibson J; Cysyk J; Weiss W; Rosenberg G
Artif Organs; 2019 Feb; 43(2):199-206. PubMed ID: 30374981
[TBL] [Abstract][Full Text] [Related]
4. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
[TBL] [Abstract][Full Text] [Related]
5. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
[TBL] [Abstract][Full Text] [Related]
6. Multi-indicator analysis of mechanical blood damage with five clinical ventricular assist devices.
Li Y; Wang H; Xi Y; Sun A; Deng X; Chen Z; Fan Y
Comput Biol Med; 2022 Dec; 151(Pt A):106271. PubMed ID: 36347061
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.
Netuka I; Kvasnička T; Kvasnička J; Hrachovinová I; Ivák P; Mareček F; Bílková J; Malíková I; Jančová M; Malý J; Sood P; Sundareswaran KS; Connors JM; Mehra MR
J Heart Lung Transplant; 2016 Jul; 35(7):860-7. PubMed ID: 27435529
[TBL] [Abstract][Full Text] [Related]
8. The effect of shear stress on the size, structure, and function of human von Willebrand factor.
Chan CH; Pieper IL; Fleming S; Friedmann Y; Foster G; Hawkins K; Thornton CA; Kanamarlapudi V
Artif Organs; 2014 Sep; 38(9):741-50. PubMed ID: 25234758
[TBL] [Abstract][Full Text] [Related]
9. A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index.
Fraser KH; Zhang T; Taskin ME; Griffith BP; Wu ZJ
J Biomech Eng; 2012 Aug; 134(8):081002. PubMed ID: 22938355
[TBL] [Abstract][Full Text] [Related]
10. Acquired von Willebrand factor deficiency is reduced in HeartMate 3 patients†.
Klaeske K; Dieterlen MT; Scholz U; Lehmann S; Garbade J; Fischer J; Jawad K; Borger MA; Meyer A
Eur J Cardiothorac Surg; 2019 Sep; 56(3):444-450. PubMed ID: 30815698
[TBL] [Abstract][Full Text] [Related]
11. Effect of pulsatility on shear-induced extensional behavior of Von Willebrand factor.
Wang Y; Nguyen KT; Ismail E; Donoghue L; Giridharan GA; Sethu P; Cheng X
Artif Organs; 2022 May; 46(5):887-898. PubMed ID: 34866200
[TBL] [Abstract][Full Text] [Related]
12. A New Mathematical Numerical Model to Evaluate the Risk of Thrombosis in Three Clinical Ventricular Assist Devices.
Li Y; Wang H; Xi Y; Sun A; Deng X; Chen Z; Fan Y
Bioengineering (Basel); 2022 May; 9(6):. PubMed ID: 35735478
[No Abstract] [Full Text] [Related]
13. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
[TBL] [Abstract][Full Text] [Related]
15. Investigation into the effect of the aspect ratio of cylindrical surface microstructure on von Willebrand factor damage.
Mei X; Zhang L; Zhu Y
Int J Artif Organs; 2022 Mar; 45(3):322-330. PubMed ID: 35075935
[TBL] [Abstract][Full Text] [Related]
16. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
[TBL] [Abstract][Full Text] [Related]
17. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
Bartoli CR; Kang J; Motomura T
J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
[TBL] [Abstract][Full Text] [Related]
18. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
[TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
[TBL] [Abstract][Full Text] [Related]
20. Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.
Coghill PA; Kanchi S; Azartash-Namin ZJ; Long JW; Snyder TA
ASAIO J; 2019 Jul; 65(5):481-488. PubMed ID: 30004942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
